Gene · 8081
Papers1,614
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,614
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An SN2-Type Strategy toward 1,2-cis-Furanosides. | CCS Chem | 2022 | 38186678 | PubTator, text mining | PubMed |
| The Effect of Treatment-Associated Mutations on HIV Replication and Transmission Cycles. | Viruses | 2022 | 36680147 | PubTator, text mining | PubMed |
| High-Level rAAV Vector Production by rAdV-Mediated Amplification of Small Amounts of Input Vector. | Viruses | 2022 | 36680104 | PubTator, text mining | PubMed |
| Characterization of Canine Adenovirus Type 2 Virus Infection Pattern in Canine and Human Cell Lines. | Adv Virol | 2022 | 36591003 | PubTator, text mining | PubMed |
Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154) and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152). | Front Immunol | 2022 | 36569867 | PubTator, text mining | PubMed |
| Comprehensive assessment on the applications of oncolytic viruses for cancer immunotherapy. | Front Pharmacol | 2022 | 36569326 | PubTator, text mining | PubMed |
| Resistance towards ChadOx1 nCoV-19 in an 83 Years Old Woman Experiencing Vaccine Induced Thrombosis with Thrombocytopenia Syndrome. | Vaccines (Basel) | 2022 | 36560466 | PubTator, text mining | PubMed |
| Laser Directed Energy Deposition of an AlMgScZr-Alloy in High-Speed Process Regimes. | Materials (Basel) | 2022 | 36556758 | PubTator, text mining | PubMed |
| Efficacy and Safety of COVID-19 Vaccines-An Update. | Diseases | 2022 | 36547198 | PubTator, text mining | PubMed |
| Fiber manipulation and post-assembly nanobody conjugation for adenoviral vector retargeting through SpyTag-SpyCatcher protein ligation. | Front Mol Biosci | 2022 | 36545512 | PubTator, text mining | PubMed |
| Effects of pre-existing anti-adenovirus antibodies on transgene expression levels and therapeutic efficacies of arming oncolytic adenovirus. | Sci Rep | 2022 | 36513733 | PubTator, text mining | PubMed |
| Oncolytic virus: A catalyst for the treatment of gastric cancer. | Front Oncol | 2022 | 36505792 | PubTator, text mining | PubMed |
| Advance in strategies to build efficient vaccines against tuberculosis. | Front Vet Sci | 2022 | 36504851 | PubTator, text mining | PubMed |
| Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein. | J Virol | 2022 | 36468859 | PubTator, text mining | PubMed |
| The protective immunity induced by intranasally inoculated serotype 63 chimpanzee adenovirus vector expressing human respiratory syncytial virus prefusion fusion glycoprotein in BALB/c mice. | Front Microbiol | 2022 | 36466668 | PubTator, text mining | PubMed |
| Nucleoside analogs for management of respiratory virus infections: mechanism of action and clinical efficacy. | Curr Opin Virol | 2022 | 36403338 | PubTator, text mining | PubMed |
| The mechanism study of Eag1 potassium channel in gastric cancer. | Transl Cancer Res | 2022 | 36388037 | PubTator, text mining | PubMed |
| Anti-Ad26 humoral immunity does not compromise SARS-COV-2 neutralizing antibody responses following Gam-COVID-Vac booster vaccination. | NPJ Vaccines | 2022 | 36379998 | PubTator, text mining | PubMed |
| Sequential use of Ad26-based vaccine regimens in NHP to induce immunity against different disease targets. | NPJ Vaccines | 2022 | 36379957 | PubTator, text mining | PubMed |
| An Overview of Rift Valley Fever Vaccine Development Strategies. | Vaccines (Basel) | 2022 | 36366303 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8081/papers?page=7